Nebenwirkungen · Rivastigmine Hexal
Rivastigmine HEXAL 1.5 mg hard capsules Rivastigmine HEXAL 3 mg hard capsules Rivastigmine HEXAL 4.5 mg hard capsules Rivastigmine HEXAL 6 mg hard capsules · Abschnitt 4.8 · PDF-Seite 8
HOS-212489 · Präparat HOS-154908
Metabolism and nutrition disorders Common Decreased appetite Common Dehydration Psychiatric disorders Common Insomnia Common Anxiety Common Restlessness Common Hallucination, visual Common Depression Not known Aggression Nervous system disorders Very common Tremor Common Dizziness Common Somnolence Common Headache Common Parkinson’s disease (worsening) Common Bradykinesia Common Dyskinesia Common Hypokinesia Common Cogwheel rigidity Uncommon Dystonia Not known Pleurothotonus (Pisa syndrome) Cardiac disorders Common Bradycardia Uncommon Arial fibrillation Uncommon Atrioventricular block Not known Sick sinus syndrome Vascular disorders Common Hypertension Uncommon Hypotension
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-20T15:07:00Z · SHA-256 bbd3efacfa6ee73c0c1ed822d126be0a9957788398f45609c5dc7a92e3109d32 · Passage b33a04664faeb1c1af828af4f9e5f4c1b3a68298129886dc5906b6382b476de7 · Zeichen 4607–6521 im Abschnitt